Your browser doesn't support javascript.
loading
Distinct outcomes, ABL1 mutation profile, and transcriptome features between p190 and p210 transcripts in adult Philadelphia-positive acute lymphoblastic leukemia in the TKI era.
Shi, Ting; Xie, Mixue; Chen, Li; Yuan, Wei; Wang, Yungui; Huang, Xin; Xie, Wanzhuo; Meng, Haitao; Lou, Yinjun; Yu, Wenjuan; Tong, Hongyan; Ye, Xiujin; Huang, Jinyan; Jin, Jie; Zhu, Honghu.
Affiliation
  • Shi T; Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, #79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China.
  • Xie M; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China.
  • Chen L; Program in Clinical Medicine, School of Medicine of Zhejiang University, Hangzhou, Zhejiang, China.
  • Yuan W; Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, #79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China.
  • Wang Y; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China.
  • Huang X; Bio-Med Big Data Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Xie W; Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Meng H; Department of Physiology, Medical College of Three Gorges University, Yichang, Hubei, China.
  • Lou Y; Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, #79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China.
  • Yu W; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China.
  • Tong H; Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, #79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China.
  • Ye X; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China.
  • Huang J; Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, #79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China.
  • Jin J; Zhejiang Province Key Laboratory of Hematology Oncology Diagnosis and Treatment, Hangzhou, China.
  • Zhu H; Department of Hematology, The First Affiliated Hospital, College of Medicine, Zhejiang University, #79 Qingchun Road, Hangzhou, 310003, Zhejiang Province, China.
Exp Hematol Oncol ; 11(1): 13, 2022 Mar 11.
Article in En | MEDLINE | ID: mdl-35277197

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Exp Hematol Oncol Year: 2022 Document type: Article Affiliation country: China Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Exp Hematol Oncol Year: 2022 Document type: Article Affiliation country: China Country of publication: Reino Unido